Digital Pathogen Accountability Governance Doctrine.

1. Introduction

The Digital Pathogen Accountability Governance Doctrine (DPAGD) is an emerging interdisciplinary legal framework concerned with establishing legal responsibility, institutional accountability and effective governance for digital technologies that create, detect, modify, simulate, distribute or amplify biological threats through interconnected digital systems.

The doctrine addresses the intersection of five major legal fields:

Digital technology and cybersecurity law.

Public health and epidemic-control law.

Biotechnology and biosafety regulation.

Artificial intelligence and algorithmic accountability.

Constitutional rights, privacy and human security.

The expression digital pathogen can encompass two related categories:

Digital biological threats: Computer-assisted biological research, pathogen-genome manipulation, synthetic biology platforms, automated laboratories and digital systems capable of facilitating biological risks.

Digital cyber-pathogens: Malicious software, compromised medical infrastructure, manipulated health databases and cyberattacks that disrupt disease surveillance, diagnostic systems, hospitals or public-health institutions.

The doctrine does not assume that digital software is legally equivalent to a biological pathogen. Rather, it examines how digital systems can generate, facilitate, conceal or amplify biological and public-health hazards.

Its central proposition is that every institution or actor exercising meaningful control over a digitally enabled biological-risk system should bear proportionate legal duties corresponding to its control, knowledge, capacity and contribution to the resulting harm.

2. Meaning and Nature of the Doctrine

Digital Pathogen Accountability Governance is based on the proposition that biological risks can no longer be governed exclusively through conventional public-health legislation.

Modern biotechnology increasingly depends on:

Artificial intelligence-assisted biological research.

Digital pathogen-genome databases.

Automated laboratory equipment.

Cloud-based genomic computing.

Synthetic biology platforms.

Digital epidemiological surveillance.

Connected diagnostic and hospital systems.

Algorithmic disease-prediction models.

These systems create new accountability questions.

For example, if an AI-supported biological research platform produces an unsafe experimental recommendation, and a laboratory implements that recommendation without adequate verification, the resulting legal responsibility may involve the software developer, laboratory operator, research institution and supervisory authorities.

The doctrine therefore rejects the assumption that technological complexity automatically eliminates legal responsibility.

3. Foundational Principles

A. Principle of Digital Biological Responsibility

Every organisation developing or operating digital infrastructure associated with biological research must adopt appropriate safeguards against foreseeable biological harm.

Responsibilities may include:

Risk assessment before deployment.

Access controls.

Research documentation.

Technical validation.

Incident reporting.

Independent safety audits.

B. Principle of Traceable Accountability

Digital biological activities should be supported by reliable records identifying relevant decisions, system modifications, authorisations and operational interventions.

This principle is particularly important when several institutions participate in a single research or diagnostic process.

C. Principle of Preventive Governance

Legal responsibility should not arise only after an epidemic, laboratory accident or cyberattack.

Regulatory institutions should identify foreseeable risks and establish preventive safeguards before potentially harmful technologies are deployed.

D. Principle of Human Oversight

Automated systems should not exercise unrestricted authority over high-consequence biological decisions.

Human review, independent validation and clearly assigned supervisory responsibility should remain important components of governance.

E. Principle of Proportionate Liability

Liability should depend on the nature of the actor's involvement, including:

Knowledge of the risk.

Degree of control.

Foreseeability of harm.

Negligence or misconduct.

Causal contribution.

Failure to comply with statutory duties.

F. Principle of Public Health Transparency

Governments and institutions should provide appropriate information concerning biological risks, disease outbreaks, technological failures and public-health emergencies.

Transparency must nevertheless be balanced against legitimate privacy, confidentiality and biosecurity restrictions.

4. Constitutional and Legislative Framework in India

The doctrine can be developed within the Indian constitutional and statutory framework, even though India does not presently have a single statute formally establishing a Digital Pathogen Accountability Governance Doctrine.

A. Constitutional provisions

ProvisionRelevance
Article 14Non-arbitrary and fair regulation of digital biological systems.
Article 19(1)(a)Access to public-health information and scientific communication.
Article 19(1)(g)Regulation of biotechnology and digital research activities in the public interest.
Article 21Protection of life, health, privacy and human dignity.
Article 32Constitutional remedies for violations of fundamental rights.
Article 47State responsibility to improve public health.
Article 48AEnvironmental protection and ecological preservation.
Article 51A(g)Fundamental duty to protect the natural environment.

Article 21 is particularly important. A biological threat generated or amplified through digital infrastructure may endanger life, health and personal liberty. The State therefore has a constitutional responsibility to maintain an effective public-health protection framework.

B. Relevant Indian legislation

1. Information Technology Act, 2000

This legislation provides a legal framework for electronic records, cybersecurity offences and protection of computer systems.

Relevant provisions include:

Section 43: Unauthorised access and damage to computer systems.

Section 66: Computer-related offences.

Section 66C: Identity theft.

Section 66D: Cheating by personation using computer resources.

Section 70: Protected systems.

Section 70A: Critical Information Infrastructure protection.

Section 70B: CERT-In and cybersecurity incident-response functions.

These provisions may become relevant where malicious digital interference affects hospitals, diagnostic infrastructure, genomic databases or public-health networks.

2. Digital Personal Data Protection Act, 2023

The Act is relevant to personal information processed through digital health platforms, subject to its statutory scope, exemptions and applicable commencement provisions.

Its significance includes:

Lawful processing of personal data.

Protection of individuals' privacy.

Data-security obligations.

Accountability of data fiduciaries.

Statutory remedies and enforcement.

Genetic and genomic information deserves particular attention because its disclosure can create risks extending beyond the individual to biological relatives.

3. Environment (Protection) Act, 1986

The Act provides an important statutory foundation for regulating activities involving hazardous substances and environmental risks.

It is relevant to biotechnology facilities, laboratory waste, biological contamination and environmental consequences of unsafe research.

4. Biological Diversity Act, 2002

This legislation provides a framework for conserving biological diversity, regulating access to biological resources and addressing associated benefit-sharing concerns.

5. Epidemic Diseases Act, 1897

The Act provides powers for special measures during dangerous epidemic disease outbreaks.

It can be relevant to emergency public-health interventions, subject to constitutional safeguards and other applicable legislation.

6. Disaster Management Act, 2005

The Act provides an institutional framework for disaster preparedness, coordination and response. Public-health emergencies may require coordination between health authorities, disaster-management institutions and digital infrastructure operators.

7. Biomedical Waste Management Rules, 2016

These Rules are important for the safe handling, treatment and disposal of biomedical waste, including waste generated by healthcare and laboratory activities.

Together, these laws create a fragmented but significant foundation for digital biological-risk governance.

5. Important Judicial Decisions and Case Laws

An important academic distinction must be maintained: there is not yet a settled body of Indian case law directly recognising the Digital Pathogen Accountability Governance Doctrine. The following judgments provide analogous principles that can support its development.

A. Indian judicial precedents

1. Vellore Citizens' Welfare Forum v. Union of India (1996) 5 SCC 647

Foundational precedent

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential components of Indian environmental law.

The Court held that:

Environmental authorities must anticipate and prevent serious environmental harm.

Scientific uncertainty cannot justify postponing preventive measures where serious or irreversible damage is threatened.

The polluter must bear the cost of compensating victims and restoring environmental damage.

Application to the doctrine: If a biotechnology institution or digital laboratory platform creates foreseeable biological hazards, regulatory authorities should not wait for a major outbreak before imposing appropriate preventive safeguards.

Indian Kanoon+2

2. M.C. Mehta v. Union of India (1987) 1 SCC 395

This case arose from the Oleum Gas Leak incident involving a hazardous industrial enterprise.

The Supreme Court developed the doctrine of absolute liability, holding that enterprises engaged in hazardous or inherently dangerous activities bear a stringent responsibility to compensate for harm caused by their activities.

Application: A digital biotechnology enterprise operating hazardous biological research infrastructure may be subject to stringent liability where applicable statutory and tort-law requirements are satisfied. The case provides a strong analogy for preventing enterprises from escaping responsibility merely because their activities involve advanced technology.

3. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

Privacy precedent

The Supreme Court recognised privacy as a constitutionally protected fundamental right under Article 21 and the broader fundamental-rights framework.

The judgment is especially significant for:

Genetic privacy.

Genomic databases.

Digital medical records.

Health surveillance.

Biometric identification.

Confidentiality of biological information.

Application: Digital pathogen surveillance must not become an unrestricted mechanism for collecting or disclosing individual health and genetic information. Public-health objectives must be pursued within constitutional limitations.

4. Shreya Singhal v. Union of India (2015) 5 SCC 1

The Supreme Court struck down Section 66A of the Information Technology Act, 2000, because of its unconstitutional restrictions on freedom of expression.

Application: Governments may need to regulate dangerous online biological misinformation, but restrictions must satisfy constitutional standards. The existence of a public-health emergency does not automatically validate vague or arbitrary restrictions on digital communication.

5. Indian Council for Enviro-Legal Action v. Union of India (1996) 3 SCC 212

The Supreme Court reinforced the polluter-pays principle and the responsibility of polluting industries to bear the cost of environmental remediation.

Application: Where a digitally controlled industrial or laboratory process causes biological contamination, the responsible enterprise may be required to finance remediation and compensation under applicable law.

6. In Re: Distribution of Essential Supplies and Services During Pandemic (2021) 7 SCC 772

The Supreme Court considered public-health administration and the distribution of essential supplies during the COVID-19 pandemic.

The proceedings highlighted the importance of:

Transparent public-health administration.

Institutional coordination.

Evidence-based decision-making.

Equitable access to essential healthcare.

Responsible government communication.

Application: Digital pathogen governance requires reliable information systems, accountable public-health decision-making and fair access to emergency medical resources.

B. International judicial precedents

7. Jacobson v. Massachusetts (1905) 197 U.S. 11

The United States Supreme Court upheld the constitutional validity of a compulsory vaccination requirement adopted under public-health powers.

Application: States may adopt reasonable public-health restrictions to address biological threats. However, digital surveillance, automated health restrictions and emergency interventions must remain subject to constitutional and legal limitations.

LII / Legal Information Institute+1

8. Compagnie Française de Navigation à Vapeur v. Louisiana State Board of Health (1902) 186 U.S. 380

The case concerned quarantine measures imposed to protect public health.

Application: It provides historical support for the proposition that public-health authorities may exercise preventive powers against infectious-disease risks, subject to the governing constitutional and statutory framework.

9. Gonzales v. Oregon (2006) 546 U.S. 243

The Supreme Court examined the limits of federal administrative authority in relation to medical practice and state regulation.

Application: Digital biological-risk governance must identify which authorities possess legal jurisdiction over research, medical practice, public-health surveillance and technology regulation. Administrative institutions cannot simply assume powers that legislation has not conferred.

6. International Legal and Regulatory Framework

Digital Pathogen Accountability Governance requires international cooperation because digital biological research, genomic databases and cloud-based laboratory systems frequently operate across national borders.

A. World Health Organization Framework, 2022

The World Health Organization published its Global Guidance Framework for the Responsible Use of the Life Sciences: Mitigating Biorisks and Governing Dual-Use Research in September 2022.

The framework recognises that life-sciences research can generate substantial public-health benefits while also creating opportunities for accidental or deliberate misuse.

It identifies shared responsibilities among:

Governments and regulatory authorities.

Scientists and research institutions.

Biotechnology companies.

Research-funding bodies.

Publishers and scientific organisations.

Security institutions.

Doctrinal significance: Biological-risk governance cannot be delegated exclusively to scientists or government regulators. It requires responsibility throughout the research and technology-development lifecycle.

World Health Organization+1

 

B. Biological Weapons Convention, 1972

The Biological Weapons Convention establishes international prohibitions concerning biological and toxin weapons.

It is relevant to the doctrine because digital technologies may facilitate activities involving biological agents, research information and technological capabilities that raise dual-use concerns.

The Convention supports international efforts to prevent biological technologies from being developed or used for prohibited purposes.

C. International Health Regulations, 2005

The International Health Regulations provide an international framework for preventing, detecting and responding to public-health emergencies of international concern.

Their relevance includes:

Disease surveillance.

Public-health notification.

International cooperation.

Emergency response.

Information-sharing between competent authorities.

Digital disease-monitoring systems can strengthen these functions, provided that data collection and sharing comply with applicable legal protections.

D. European Union Artificial Intelligence Act, 2024

The European Union Artificial Intelligence Act (Regulation (EU) 2024/1689) provides a risk-based regulatory framework for AI systems.

Its provisions concerning risk management, data governance, technical documentation and human oversight are relevant to high-risk AI applications.

For example, an AI system used in medical diagnosis or biological-risk assessment may require appropriate risk-management and data-governance safeguards depending on its intended purpose and legal classification.

The Act provides a useful comparative model for developing accountability requirements for AI-enabled biological research.

EUR-Lex+1

 

7. Institutional Accountability Structure

The doctrine requires a multi-level governance architecture.

Institution or actorPrincipal accountability
Central GovernmentNational policy and regulatory coordination
Health authoritiesDisease surveillance and emergency response
Biotechnology regulatorsOversight of relevant biological activities
Cybersecurity authoritiesProtection of critical digital infrastructure
Research institutionsLaboratory safety and research integrity
AI developersSystem reliability and appropriate risk controls
Healthcare institutionsSafe use of digital diagnostic systems
Private laboratoriesBiosafety and operational compliance
Data fiduciariesApplicable personal-data protection obligations
International organisationsCross-border cooperation and standards

In India, this architecture would involve coordination among the Ministry of Health and Family Welfare, the Department of Biotechnology, the Ministry of Electronics and Information Technology, relevant environmental authorities and cybersecurity institutions.

The precise jurisdiction of each authority must be determined by its enabling legislation.

8. Liability Under the Digital Pathogen Accountability Governance Doctrine

One of the most important aspects of the doctrine is the identification of legal responsibility when a digital system contributes to biological harm.

A. Developer liability

Software and AI developers may face legal responsibility where they negligently design, test, secure or maintain systems in circumstances creating foreseeable harm.

Potential legal questions include:

Whether foreseeable risks were assessed.

Whether appropriate safeguards were implemented.

Whether known vulnerabilities were addressed.

Whether limitations were properly communicated.

Whether the developer complied with applicable statutory obligations.

B. Research institution liability

Research institutions may be responsible for inadequate supervision, unsafe research practices, deficient security arrangements or failure to comply with biosafety requirements.

C. Corporate liability

Biotechnology companies may face civil, regulatory or criminal consequences depending on the nature of the misconduct and the applicable legislation.

Corporate responsibility becomes especially significant where commercial pressures encourage institutions to disregard safety protocols.

D. Governmental accountability

Government authorities may be questioned where they:

Ignore credible warnings.

Fail to implement statutory safeguards.

Neglect public-health surveillance.

Improperly disclose sensitive health information.

Exercise emergency powers arbitrarily.

Fail to coordinate an effective response.

Government liability is not automatic merely because harm occurs. It depends on the applicable constitutional, statutory and public-law principles.

E. Individual professional liability

Scientists, laboratory administrators, healthcare professionals and system operators may face professional or legal consequences for negligence, deliberate misconduct or statutory violations.

F. Intermediary responsibility

Digital platforms and cloud-service providers may become relevant where they facilitate the distribution, storage or processing of biological research information.

Their liability must be determined under the applicable statutory framework, including the Information Technology Act and relevant intermediary rules. Mere provision of technological infrastructure does not automatically establish liability for every subsequent misuse.

9. Digital Pathogen Risk Classification

A workable governance doctrine should classify digital biological risks according to their potential consequences.

Risk categoryNature of riskGovernance response
Category IOrdinary digital health-data errorsData protection and correction
Category IIDiagnostic-system manipulationClinical validation and cybersecurity
Category IIICompromised laboratory infrastructureBiosafety investigation and incident response
Category IVDigital facilitation of serious biological misuseEnhanced oversight and restricted access
Category VCross-border biological emergency amplified by digital systemsNational and international coordination

This is a proposed academic classification, not an existing statutory classification.

The regulatory response should be proportionate to the actual risk rather than the mere presence of AI or biotechnology.

10. Due Diligence and Compliance Obligations

The doctrine proposes a continuous compliance system covering the complete lifecycle of digitally enabled biological research.

Its essential elements include:

1. Pre-deployment assessment: Evaluate biological, technological, environmental and public-health risks before introducing a system.

2. Institutional authorisation: Ensure that research and operations receive appropriate regulatory and institutional approval.

3. Secure digital infrastructure: Maintain cybersecurity safeguards for genomic databases, diagnostic networks and laboratory systems.

4. Independent validation: Require suitable scientific and technical verification of high-consequence outputs.

5. Human supervision: Ensure that consequential decisions are not left entirely to automated systems.

6. Incident reporting: Establish legally appropriate mechanisms for reporting cybersecurity breaches, laboratory accidents and biological-risk incidents.

7. Evidence preservation: Maintain reliable records for subsequent investigation and judicial scrutiny.

8. Periodic auditing: Review system performance, safety compliance and institutional responsibility.

9. Remediation and compensation: Provide appropriate mechanisms for correcting harm and compensating affected persons where legal liability is established.

10. International coordination: Cooperate with relevant international institutions when biological risks cross national boundaries.

11. Relationship Between Digital Pathogen Governance and Fundamental Rights

The doctrine must protect public health without transforming emergency governance into unrestricted surveillance.

A. Right to privacy

Genetic information, medical records and disease-related personal information require appropriate protection.

B. Right to health

Digital surveillance and diagnostic technologies should support timely, accessible and effective healthcare.

C. Freedom of expression

Public-health misinformation may require proportionate regulatory responses, but scientific disagreement and legitimate criticism must not be arbitrarily suppressed.

D. Equality and non-discrimination

Automated disease-risk systems must not unfairly discriminate against individuals based on genetic information, disability, socioeconomic status or other protected characteristics.

E. Human dignity

People affected by infectious diseases must not be subjected to arbitrary exclusion, public humiliation or unjustified restrictions on their liberty.

The doctrine therefore seeks to balance collective biological security with individual constitutional protection.

12. Major Challenges in Implementing the Doctrine

Several structural challenges complicate the implementation of Digital Pathogen Accountability Governance.

1. Jurisdictional fragmentation: Biological research, digital infrastructure, healthcare and environmental protection are regulated by different institutions.

2. Attribution difficulties: Establishing whether biological harm resulted from human negligence, software malfunction, cyber interference or natural transmission can be technically difficult.

3. Artificial intelligence opacity: Complex AI systems may make it difficult to identify how a particular output was generated.

4. Cross-border jurisdiction: Digital biological information can be stored, processed and accessed in several countries.

5. Dual-use research: Research intended to improve public health may also create capabilities that can be misused.

6. Regulatory lag: Technological innovation can develop faster than legislative and institutional responses.

7. Scientific uncertainty: Regulators may need to act before the precise nature and magnitude of biological risks are established.

8. Corporate accountability gaps: Complex contractual arrangements may distribute responsibility across developers, laboratories, cloud providers and research institutions.

9. Privacy versus surveillance: Public-health monitoring must be balanced against constitutional privacy protections.

10. Unequal technological capacity: Developing countries may lack adequate laboratories, cybersecurity infrastructure and specialised regulatory personnel.

13. Proposed Development of a Digital Pathogen Accountability Governance Act in India

A dedicated legislative framework could consolidate and clarify responsibilities that currently arise under multiple laws.

The proposed Act could contain the following chapters:

Proposed chapterSubject
Chapter IPreliminary definitions and scope
Chapter IIRegulation of digitally enabled biological research
Chapter IIIAI-assisted biotechnology accountability
Chapter IVDigital biosafety and cybersecurity standards
Chapter VGenomic and biological-data protection
Chapter VIInstitutional responsibility and liability
Chapter VIIEmergency response and incident reporting
Chapter VIIICross-border cooperation
Chapter IXIndependent regulatory supervision
Chapter XCompensation, penalties and judicial remedies

Proposed regulatory institutions

A specialised Digital Biological Risk Regulatory Authority could be established with statutory independence and clearly defined jurisdiction.

Its responsibilities could include:

Maintaining national digital biological-risk standards.

Coordinating relevant government agencies.

Developing institutional audit requirements.

Supervising high-risk digital biotechnology applications.

Establishing incident-reporting procedures.

Monitoring compliance with applicable biosafety obligations.

Facilitating international regulatory cooperation.

Such an authority should complement rather than unnecessarily duplicate existing statutory regulators.

14. Illustrative Hypothetical Case Study

Consider a biotechnology research institution using an AI-assisted genomic analysis platform.

The platform generates an inaccurate biological-risk assessment. The institution fails to independently validate the output and proceeds with an inadequately supervised research activity. A biological safety incident subsequently occurs.

Under the proposed doctrine, the investigation would examine:

Whether the AI developer implemented appropriate safeguards.

Whether the research institution followed applicable biosafety standards.

Whether the laboratory maintained adequate supervision.

Whether regulatory authorities received the necessary information.

Whether the incident was reported promptly.

Whether the conduct of each participant contributed to the harm.

Whether affected individuals are entitled to compensation.

The doctrine would not automatically impose liability on every participant. Responsibility would be established through evidence, applicable legal duties and causal analysis.

This approach prevents technological complexity from becoming an excuse for institutional irresponsibility.

15. Critical Academic Analysis

The greatest contribution of the Digital Pathogen Accountability Governance Doctrine is its attempt to move biological-risk regulation from a predominantly reactive model towards an integrated system of preventive, technological and institutional accountability.

Traditional public-health law concentrates substantially on disease detection, containment, treatment and emergency intervention.

Traditional cybersecurity law concentrates on unauthorised access, information-system integrity and digital infrastructure protection.

Traditional biotechnology regulation concentrates on research safety, biological materials and scientific procedures.

However, digitally enabled biological activities create situations in which these regulatory domains overlap.

The doctrine therefore proposes a unified accountability model based on three dimensions:

First: Technological accountability. Every relevant digital system must be evaluated according to its capabilities, foreseeable risks and operational limitations.

Second: Institutional accountability. Organisations must establish identifiable responsibilities for research approval, safety supervision, information management and emergency response.

Third: Constitutional accountability. Governmental and private institutional conduct must remain consistent with applicable legal obligations, human dignity, privacy and public-health protections.

A particularly important theoretical question concerns the allocation of responsibility when no single actor independently causes the harm. The doctrine addresses this through a contribution-based approach that examines control, knowledge, foreseeability, negligence and causal connection.

It also raises an important question of intergenerational justice: whether present generations can permit uncontrolled development of technologies that create potentially irreversible biological or ecological risks for future generations.

The precautionary principle, sustainable development and constitutional protection of life provide important foundations for answering this question.

16. Conclusion

The Digital Pathogen Accountability Governance Doctrine represents a proposed framework for regulating the convergence of digital technology, artificial intelligence, biotechnology, cybersecurity and public health.

Its central objective is to ensure that technological innovation does not create accountability-free spaces in which biological risks can be generated, amplified or concealed.

The Indian constitutional framework, particularly Articles 14, 19, 21 and 47, together with environmental legislation, information technology law and public-health regulation, provides important foundations for developing this framework.

The judgments in Vellore Citizens' Welfare Forum, M.C. Mehta, Puttaswamy and Shreya Singhal offer complementary principles concerning precaution, liability, privacy and constitutional limitations.

Ultimately, the doctrine advances a fundamental proposition:

No institution should be permitted to exercise technological or biological power without corresponding legal responsibility, preventive safeguards and mechanisms of public accountability.

Its long-term significance lies in establishing a legal governance architecture in which biological security, digital integrity, scientific freedom and constitutional rights operate together.

17. Selected Authorities and References

AuthorityPrincipal legal contribution
Vellore Citizens' Welfare Forum v. Union of India (1996)Precautionary principle and polluter pays
M.C. Mehta v. Union of India (1987)Absolute liability
Indian Council for Enviro-Legal Action v. Union of India (1996)Environmental remediation
K.S. Puttaswamy v. Union of India (2017)Constitutional privacy
Shreya Singhal v. Union of India (2015)Digital freedom of expression
In Re: Distribution of Essential Supplies and Services During Pandemic (2021)Public-health administration
Jacobson v. Massachusetts (1905)State public-health powers
Gonzales v. Oregon (2006)Limits of administrative authority

Principal international instruments:

Biological Weapons Convention, 1972.

International Health Regulations, 2005.

WHO Global Guidance Framework for the Responsible Use of the Life Sciences, 2022.

EU Artificial Intelligence Act, 2024.

Convention on Biological Diversity, 1992.

Final academic observation: Digital Pathogen Accountability Governance should be understood as a proposed legal doctrine developed from existing constitutional, environmental, public-health, cybersecurity and biotechnology principles—not as an already recognised independent cause of action or settled judicial doctrine.

I can also develop this subject into a PhD-level academic monograph, with comparative Indian, UK, EU and US jurisprudence, statutory analysis and a proposed model legislative framework.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT